Index NDX, S&P 500
P/E 39.44
EPS (ttm) 1.62
Insider Own 1.55%
Shs Outstand 397.68M
Perf Week -42.68%
Market Cap 25.45B
Forward P/E 31.65
EPS next Y 2.02
Insider Trans -3.55%
Shs Float 391.50M
Perf Month -43.62%
Income 666.90M
PEG 2.18
EPS next Q 0.44
Inst Own 94.12%
Short Float 2.66%
Perf Quarter -53.63%
Sales 3.93B
P/S 6.47
EPS this Y 11.96%
Inst Trans -0.34%
Short Ratio 3.66
Perf Half Y -49.41%
Book/sh 6.08
P/B 10.53
EPS next Y 18.83%
ROA 9.79%
Short Interest 10.42M
Perf Year -51.03%
Cash/sh 7.85
P/C 8.16
EPS next 5Y 18.05%
ROE 29.41%
52W Range 74.75 - 142.00
Perf YTD -48.42%
Dividend Est. -
P/FCF 38.24
EPS past 5Y -
ROI 13.32%
52W High -54.93%
Beta 1.16
Dividend TTM -
Quick Ratio 2.48
Sales past 5Y 28.80%
Gross Margin 62.75%
52W Low -14.38%
ATR (14) 6.27
Dividend Ex-Date -
Current Ratio 2.82
EPS Y/Y TTM 85.77%
Oper. Margin 17.32%
RSI (14) 11.68
Volatility 4.09% 3.02%
Employees 9600
Debt/Eq 1.07
Sales Y/Y TTM 23.05%
Profit Margin 16.95%
Recom 1.63
Target Price 102.90
Option/Short Yes / Yes
LT Debt/Eq 1.06
EPS Q/Q 26.60%
Payout 0.00%
Rel Volume 18.85
Prev Close 107.85
Sales Surprise -3.17%
EPS Surprise 11.34%
Sales Q/Q 15.26%
Earnings Jul 25 AMC
Avg Volume 2.85M
Price 64.00
SMA20 -43.01%
SMA50 -45.43%
SMA200 -45.87%
Trades
Volume 53,713,862
Change -40.66%
Date
Action
Analyst
Rating Change
Price Target Change
Today Downgrade
Robert W. Baird
Outperform → Neutral
$161 → $80
Today Downgrade
JP Morgan
Overweight → Neutral
$145 → $75
May-30-24 Initiated
Redburn Atlantic
Neutral
$130
Mar-12-24 Initiated
RBC Capital Mkts
Outperform
$165
May-30-23 Resumed
Morgan Stanley
Equal-Weight
$131
Apr-17-23 Upgrade
Raymond James
Outperform → Strong Buy
$127 → $138
Mar-29-23 Initiated
UBS
Buy
$142
Jan-26-23 Initiated
Wolfe Research
Outperform
$121
Oct-18-22 Initiated
Barclays
Equal Weight
$103
Oct-12-22 Initiated
Jefferies
Buy
$125
Jul-15-22 Initiated
Bernstein
Outperform
$105
Mar-02-22 Resumed
BofA Securities
Buy
$500
Feb-03-22 Upgrade
BTIG Research
Neutral → Buy
$535
Jan-19-22 Upgrade
Wells Fargo
Equal Weight → Overweight
$575
Jan-07-22 Upgrade
Guggenheim
Neutral → Buy
$580
Oct-18-21 Downgrade
Guggenheim
Buy → Neutral
Jul-21-21 Resumed
Cowen
Outperform
$540 → $525
May-28-21 Upgrade
Wells Fargo
Underweight → Equal Weight
$380
May-25-21 Initiated
Barclays
Overweight
$500
Apr-15-21 Initiated
Atlantic Equities
Overweight
$438
Show Previous Ratings
Today 06:33PM
05:12PM
04:17PM
(Investor's Business Daily)
04:16PM
04:07PM
03:17PM
Loading…
03:17PM
02:23PM
01:55PM
01:26PM
01:14PM
12:27PM
(Associated Press Finance)
12:19PM
12:03PM
10:42AM
10:33AM
10:25AM
Loading…
10:25AM
10:19AM
09:37AM
(The Wall Street Journal)
07:36AM
07:35AM
01:05AM
12:34AM
Jul-25-24 11:00PM
09:47PM
06:12PM
05:44PM
05:15PM
05:09PM
(Investor's Business Daily)
04:14PM
(Associated Press Finance)
04:03PM
07:31AM
Loading…
Jul-23-24 07:31AM
12:06AM
Jul-17-24 08:00AM
(Investor's Business Daily)
Jul-15-24 09:45AM
Jul-14-24 10:00AM
Jul-08-24 10:28AM
Jul-05-24 11:54AM
Jul-04-24 10:00AM
Jun-28-24 07:28PM
06:08PM
05:20PM
Jun-27-24 12:27PM
08:30AM
Jun-26-24 06:48AM
Jun-25-24 06:00AM
Jun-21-24 12:24PM
08:00AM
Jun-20-24 07:15AM
06:05AM
Jun-19-24 06:02AM
Jun-18-24 03:51PM
01:12PM
10:48AM
09:45AM
Jun-17-24 07:03AM
Jun-06-24 10:31AM
Jun-05-24 06:06AM
06:00AM
Jun-04-24 10:24PM
01:21PM
07:00AM
06:20AM
Jun-03-24 06:56PM
04:04PM
08:35AM
07:45AM
May-30-24 05:50AM
May-29-24 02:30PM
08:30AM
08:30AM
May-27-24 12:55PM
09:50AM
May-23-24 05:21AM
May-20-24 07:22AM
04:00AM
May-19-24 08:09AM
May-17-24 07:05AM
May-16-24 07:00PM
May-14-24 01:01PM
May-13-24 04:30PM
08:45AM
May-10-24 03:25PM
May-04-24 06:18AM
May-03-24 10:00AM
Apr-30-24 03:03PM
(Investor's Business Daily)
12:45PM
10:31AM
09:00AM
Apr-29-24 09:45AM
Apr-26-24 04:11PM
(Investor's Business Daily) -9.91%
03:09PM
11:37AM
11:08AM
10:53AM
10:25AM
07:29AM
07:09AM
(Thomson Reuters StreetEvents)
01:30AM
01:03AM
Apr-25-24 08:56PM
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Brown Michael Jon EVP Chief Legal Officer Jun 28 '24 Sale 114.29 659 75,317 66,901 Jun 28 05:34 PM FOLETTA MARK G Director Jun 18 '24 Sale 116.79 3,306 386,122 56,398 Jun 20 04:50 PM FOLETTA MARK G Director Jun 17 '24 Sale 117.26 2,694 315,907 59,704 Jun 20 04:50 PM Heller Bridgette P Director Jun 14 '24 Sale 113.55 1,000 113,550 25,349 Jun 18 07:16 PM Sylvain Jereme M EVP Chief Financial Officer Jun 10 '24 Sale 115.05 745 85,713 84,948 Jun 11 06:39 PM Leach Jacob Steven EVP Chief Operating Officer Jun 10 '24 Sale 115.05 745 85,713 265,577 Jun 11 06:38 PM Stern Sadie EVP Chief HR Officer Jun 10 '24 Sale 115.05 427 49,127 75,877 Jun 11 06:39 PM Brown Michael Jon EVP Chief Legal Officer May 31 '24 Sale 119.24 652 77,744 67,560 May 31 05:27 PM Dolan Matthew Vincent EVP Strategy and Corporate Dev May 15 '24 Sale 126.58 2,423 306,703 40,075 May 16 04:04 PM Brown Michael Jon EVP Chief Legal Officer Apr 30 '24 Sale 126.25 629 79,411 68,212 May 02 05:07 PM Dolan Matthew Vincent EVP Strategy and Corporate Dev Apr 15 '24 Sale 137.81 1,990 274,242 42,377 Apr 16 04:16 PM SAYER KEVIN R President CEO and Chairman Apr 08 '24 Sale 138.30 49,633 6,864,136 283,893 Apr 10 04:04 PM Brown Michael Jon EVP Chief Legal Officer Mar 28 '24 Sale 140.04 2,624 367,472 68,682 Mar 29 07:30 PM Stern Sadie EVP Chief Human Resources Mar 25 '24 Sale 140.00 4,137 579,180 76,304 Mar 26 04:46 PM Dolan Matthew Vincent EVP Strategy & Corp Dev Mar 15 '24 Sale 130.21 4,203 547,259 44,367 Mar 19 04:55 PM SAYER KEVIN R President CEO and Chairman Mar 12 '24 Sale 133.36 81,007 10,802,803 333,526 Mar 14 05:40 PM Stern Sadie EVP Chief Human Resources Mar 12 '24 Sale 133.61 20,321 2,715,006 80,441 Mar 14 05:40 PM Leach Jacob Steven EVP Chief Operating Officer Mar 12 '24 Sale 134.41 14,639 1,967,638 273,913 Mar 14 05:40 PM Sylvain Jereme M EVP Chief Financial Officer Mar 12 '24 Sale 134.41 11,661 1,567,363 85,534 Mar 14 05:40 PM Brown Michael Jon EVP Chief Legal Officer Mar 12 '24 Sale 134.41 8,799 1,182,680 71,306 Mar 14 05:39 PM Dolan Matthew Vincent EVP Strategy and Corporate Mar 12 '24 Sale 134.41 6,710 901,896 48,570 Mar 14 05:39 PM Lawver Teri L EVP Chief Commercial Officer Mar 12 '24 Sale 134.41 4,764 640,333 66,641 Mar 14 05:39 PM Sylvain Jereme M EVP Chief Financial Officer Feb 20 '24 Sale 116.73 3,363 392,563 71,142 Feb 21 05:48 PM SAYER KEVIN R President, CEO and Chairman Jan 16 '24 Sale 123.63 37,325 4,614,669 362,841 Jan 17 06:49 PM Leach Jacob Steven EVP Chief Operating Officer Jan 16 '24 Sale 123.63 3,978 491,819 262,499 Jan 17 06:49 PM Stern Sadie EVP Chief Human Resources Jan 16 '24 Sale 123.63 2,902 358,788 79,051 Jan 17 06:56 PM Sylvain Jereme M EVP Chief Financial Officer Jan 16 '24 Sale 123.63 2,734 338,018 74,505 Jan 17 06:54 PM ALTMAN STEVEN R Director Jan 16 '24 Sale 122.86 1,568 192,652 53,132 Jan 17 06:47 PM AUGUSTINOS NICHOLAS Director Dec 15 '23 Sale 123.02 3,976 489,128 34,040 Dec 18 04:32 PM ALTMAN STEVEN R Director Dec 15 '23 Sale 122.77 2,000 245,548 54,700 Dec 18 04:31 PM ALTMAN STEVEN R Director Dec 12 '23 Sale 120.00 3,000 360,004 56,700 Dec 13 04:18 PM Stern Sadie EVP Chief Human Resources Offi Dec 11 '23 Sale 117.66 392 46,123 76,008 Dec 11 06:15 PM Brown Michael Jon EVP Chief Legal Officer Dec 01 '23 Sale 114.56 3,612 413,774 58,394 Dec 04 06:10 PM Pacelli Steven Robert EVP Managing Director Dexcom V Nov 24 '23 Sale 110.80 411 45,539 124,775 Nov 27 04:00 PM Stern Sadie EVP Chief Human Resources Offi Nov 22 '23 Sale 110.00 1,176 129,360 76,400 Nov 24 03:51 PM ALTMAN STEVEN R Director Nov 15 '23 Sale 101.26 1,000 101,256 59,700 Nov 15 06:36 PM Naganathan Girish EVP Chief Technology Officer Nov 09 '23 Sale 93.27 2,725 254,161 47,725 Nov 27 07:34 PM Regan Barry J. EVP Operations Nov 08 '23 Sale 95.22 2,019 192,249 64,250 Nov 08 04:05 PM Pacelli Steven Robert EVP Managing Director Dexcom V Oct 23 '23 Sale 85.75 411 35,243 125,186 Oct 23 07:43 PM ALTMAN STEVEN R Director Oct 16 '23 Sale 77.58 1,000 77,580 60,700 Oct 17 04:15 PM Pacelli Steven Robert EVP Managing Director Dexcom V Sep 22 '23 Sale 88.40 411 36,332 125,597 Sep 22 06:30 PM ALTMAN STEVEN R Director Sep 15 '23 Sale 101.50 1,000 101,495 61,700 Sep 19 04:43 PM Heller Bridgette P Director Sep 12 '23 Sale 106.56 600 63,936 23,731 Sep 13 07:55 PM Dolan Matthew Vincent SVP Corporate Strategy-Develop Sep 01 '23 Sale 102.32 56 5,730 33,569 Sep 01 06:40 PM Pacelli Steven Robert EVP Managing Director Dexcom V Aug 23 '23 Sale 107.03 411 43,989 126,008 Aug 23 05:42 PM Sylvain Jereme M EVP Chief Financial Officer Aug 22 '23 Sale 104.38 1,844 192,477 72,867 Aug 22 04:04 PM Stern Sadie EVP Chief Human Resources Offi Aug 09 '23 Sale 110.71 392 43,398 81,682 Aug 11 03:59 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite